Patients will receive a standardized treatment for exacerbation including systemic corticosteroids , inhaled bronchodilators and supplementary oxygen if needed and will be randomized to additional treatment with placebo or antibiotic ( oral sultamicillin ) for five days.The primary endpoint is clinical failure defined by need for additional antibiotic treatment until day 30 .